Essenzaa Lifescience Limited - Company Profile

It is a pharma public limited company based in Mumbai, Maharashtra, India, established in 2012.
2012 Mumbai, Maharashtra, India Under Liquidation
Last Updated:
Access Report
About Essenzaa Lifescience Limited

Essenzaa Lifescience Limited, a under liquidation public limited company, was established on 10 February 2012 in Mumbai, Maharashtra, India. Engaging in pharmaceutical retailers & distributors within the manufacturing sector, it holds CIN: U36109MH2012PLC226651. Registered under ROC Roc Mumbai. it is unlisted. It has an authorized capital of ₹1.00 Cr and a paid-up capital of ₹1.00 Cr.

Formerly known as Probiotic Nutraceutical Limited. It upholds a compliant status. Its leadership includes Rajkumar Shamlal Jaiswal (Irp/Rp/Liquidator), Mayur Balubhai Shah (Additional Director), Manoj Balubhai Shah (Director). Past directors included Manan Shah Mahesh, Siddharth Manoj Shah, Tarang Mayurbhai Shah. It holds ₹10.65 Cr open charges and no settled loans. Its latest AGM occurred on 30 September 2022, with the balance sheet filed on 31 March 2022. It is based at 115, B-Wing, Western Edge - 2, Western Express Highway, Borivali (East), ,, Mumbai, Maharashtra, 400066.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U36109MH2012PLC226651

  • Registration Number

    226651

  • Incorporation Date

    10 February 2012

  • Authorized Capital

    ₹1.00 Cr

  • Paid-Up Capital

    ₹1.00 Cr

  • ROC Code

    Roc Mumbai

  • Listing Status

    Unlisted

  • Company Status

    Under Liquidation

Key Metrics
  • Authorised Capital ₹ 1.00 Cr
  • Paid Up Capital ₹ 1.00 Cr
  • Company Age 14 Year, 3 Months
  • Last Filing with ROC 31 Mar 2022
  • Open Charges ₹ 10.65 Cr
  • Revenue Growth **** 56.44%
  • Profit Growth **** 196.27%
  • Ebitda **** 34.08%
  • Net Worth 5.17%
  • Total Assets **** 16.52%
Company report

Essenzaa Lifescience Limited

Company Report FY 2026-2027

Comprehensive Company Insights

Explore comprehensive insights into Essenzaa Lifescience Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Essenzaa Lifescience Limited?
Current Directors
Name Designation Appointment Date Status
Rajkumar Shamlal Jaiswal Irp/Rp/Liquidator 29 Nov 2023 Current
Mayur Balubhai Shah Additional Director 26 Oct 2020 Current
Manoj Balubhai Shah Director 10 Feb 2012 Current
Arihant Nenawati Irp/Rp/Liquidator 21 Feb 2025 Current
Sneha Laxman Bhandare Additional Director 26 Oct 2020 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Director 30 Jan 2020 Past
Pramod Abcsdd Director 31 Oct 2020 Past
Pramod Abcsdd Director 10 May 2018 Past
Pramod Abcsdd Director 31 Oct 2020 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Essenzaa Lifescience.

Essenzaa Lifescience Limited, for the financial year ended 2020, experienced significant growth in revenue, with a 56.44% increase. The company also saw a substantial improvement in profitability, with a 196.27% increase in profit. The company's net worth moved up by a moderate rise of 5.17%.

Essenzaa Lifescience revenue growth over time
Essenzaa Lifescience profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
 56.44%
*******
*******
*******
*******
Revenue from Operations
*******
 59.29%
*******
*******
*******
*******
Total Assets
*******
 16.52%
*******
*******
*******
*******
Profit or Loss
*******
 196.27%
*******
*******
*******
*******
Net Worth
*******
 5.17%
*******
*******
*******
*******
EBITDA
*******
 34.08%
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Essenzaa Lifescience?

In 2020, Essenzaa Lifescience had a promoter holding of 92.00% and a public holding of 8.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

Charges (Loans)
Open Charges

₹106,500,000.00

Satisfied Charges

₹0

Charges Breakdown by Lending Institutions
  • Bank Of India : 10.65 Cr
Latest Charge Details
Date Lender Amount Status
07 Oct 2016 Bank Of India ₹5.81 Cr Open
19 Jan 2013 Bank Of India ₹4.84 Cr Open

Explore comprehensive loan charge details -

How Many Employees Work at Essenzaa Lifescience?

Unlock and access historical data on people associated with Essenzaa Lifescience, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Essenzaa Lifescience, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Essenzaa Lifescience's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Essenzaa Lifescience
Recent Activity within the Organization
  • Director Appointment

    Arihant Nenawati was appointed as a IRP/RP/Liquidator was appointed as a IRP/RP/Liquidator on 21 Feb 2025 & has been associated with this company since 1 year 2 months . was recorded as a recent event.

  • Director Appointment

    Progress on Rajkumar Shamlal Jaiswal was appointed as a IRP/RP/Liquidator was appointed as a IRP/RP/Liquidator on 29 Nov 2023 & has been associated with this company since 2 years 5 months . was documented.

  • Annual General Meeting

    Essenzaa Lifescience Limited last Annual general meeting of members was held on 30 Sep 2022 as per latest MCA records. was recorded as a recent event.

  • Balance Sheet

    Progress on Essenzaa Lifescience Limited has filed its annual Financial statements for the year ended 31 Mar 2022 with Roc Mumbai. was documented.

  • Director Appointment

    The activity Mayur Balubhai Shah was appointed as a Additional Director was appointed as a Additional Director on 26 Oct 2020 & has been associated with this company since 5 years 6 months . was completed.

  • Director Appointment

    The activity Sneha Laxman Bhandare was appointed as a Additional Director was appointed as a Additional Director on 26 Oct 2020 & has been associated with this company since 5 years 6 months . was completed.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Essenzaa Lifescience Limited?

The CIN of Essenzaa Lifescience Limited is U36109MH2012PLC226651.

Where is Essenzaa Lifescience Limited headquartered?

Essenzaa Lifescience Limited is headquartered at 115, B-Wing, Western Edge - 2, Western Express Highway, Borivali (East), ,, Mumbai, Maharashtra, 400066.

When was Essenzaa Lifescience Limited incorporated?

Essenzaa Lifescience Limited was incorporated on 10 February 2012.

Who are the current directors of Essenzaa Lifescience Limited?

The current directors of Essenzaa Lifescience Limited are

What is the primary industry of Essenzaa Lifescience Limited?

The primary industry of Essenzaa Lifescience Limited is Manufacturing.

Is Essenzaa Lifescience Limited a listed company?

Essenzaa Lifescience Limited is unlisted.

What is the capital structure of Essenzaa Lifescience Limited?

The authorized capital of Essenzaa Lifescience Limited is ₹1.00 Cr, and the paid-up capital is ₹1.00 Cr.

What is the compliance status of Essenzaa Lifescience Limited?

The compliance status of Essenzaa Lifescience Limited is Compliant.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available